Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies

Eli Lilly and Company (LLY) announced a settlement agreement with Totality Medispa that sold compounded products in the name of its popular tirzepatide drugs, Mounjaro and Zepbound. The medical spa coaxed customers into believing that its compounded tirzepatide products have undergone clinical tests and have been proven safe and effective.Eli Lilly’s Mounjaro was launched in mid-2022 for type II diabetes. Zepbound was launched in November 2023 for patients who were obese or overweight with weight-related co ...